The Annals of pharmacotherapy

Keyphrases

Publications

2024

Elizabeth M Foster, James C Coons, Elena A Puccio, Danine Sullinger, Rachel Ibrahim, Joseph Ibrahim, Gavin W Hickey, Edward Horn, Vincent Mosesso, Ryan M Rivosecchi
Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System. The Annals of pharmacotherapy (2024)
Alexa J Luboff, David L DeRemer
Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer. The Annals of pharmacotherapy (2024)
Natasha N Pettit, Kristy M Shaeer, Elias B Chahine
Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection. The Annals of pharmacotherapy (2024)
Miriam Rodríguez Fernández, Ana Concepción Sánchez Cerviño, Ana Codonal Demetrio, Nagore Lois Martínez, Benito García Díaz
Increased Theophylline Plasma Concentrations in a Patient With Covid-19. The Annals of pharmacotherapy (2024)
Emily M Hitt
Rozanolixizumab: A New Therapy in the Treatment of Myasthenia Gravis. The Annals of pharmacotherapy (2024)
Minji Jung, Beom-Jin Lee, Sukhyang Lee, Jaekyu Shin
Low-Intensity Statin Plus Ezetimibe Versus Moderate-Intensity Statin for Primary Prevention: A Population-Based Retrospective Cohort Study in Asian Population. The Annals of pharmacotherapy (2024)
Matthew Thaller, Adrian Wong, Tuyen Yankama, Ifeoma Mary Eche, Pansy Elsamadisi
Evaluation of Clinical Outcomes Associated With Phenobarbital With Taper Compared to No Taper for the Management of Alcohol Withdrawal Syndrome. The Annals of pharmacotherapy (2024)
Jacob P Counts, Joshua Arnold, Sara A Atyia, Stella Ogake, Rachel M Smith, Bruce A Doepker
The Effect of Albumin Replacement on Vasopressor Duration in Septic Shock in Patients With Hypoalbuminemia. The Annals of pharmacotherapy (2024)
Yi Zhao, Yuzhou Zhang, Lin Yang, Kanghuai Zhang, Sha Li
Safety Profile of Selective Serotonin Reuptake Inhibitors in Real-World Settings: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System. The Annals of pharmacotherapy (2024)
Abigail M Servais, Scott Lundgren, Stephanie Bowman, Douglas Stoller, Adam Burdorf, Marshall Hyden, Brian Lowes, Ronald Zolty, Don Klepser, Heidi Brink
Preoperative Amiodarone and Primary Graft Dysfunction in Heart Transplantation. The Annals of pharmacotherapy (2024)
Daniel T Anderson, Divisha Sharma, Aaron M Chase, Zoheb Irshad Sulaiman, August H Anderson, Ashley L Huggett, Joshua Eudy
Evaluation of Short Versus Long Courses of Antibiotics in Critically Ill Patients With Gram-Negative Bloodstream Infections. The Annals of pharmacotherapy (2024)
Christopher B Johns, Travis W Fleming, Skyler R Brown, Rebekah B Black, Anthony Shaun Rowe
Incidence of Hypertriglyceridemia in Patients on Propofol, Clevidipine, or Both. The Annals of pharmacotherapy (2024)
David K Choi, Michelle Becker, Marina Ivanov, Shubha Bhat
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2024)
Ainhoa Gómez-Lumbreras, Lorenzo Villa-Zapata
Exploring Safety in Gender-Affirming Hormonal Treatments: An Observational Study on Adverse Drug Events Using the Food and Drug Administration Adverse Event Reporting System Database. The Annals of pharmacotherapy (2024)
Myriam Agrebi, Dhouha Sahnoun, Najet Ghariani, Mohamed Denguezli, Chaker Ben Salem
Amiodarone-Induced Psoriasiform Dermatitis. The Annals of pharmacotherapy (2024)
Haley N Johnson, Lalita Prasad-Reddy
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease. The Annals of pharmacotherapy (2024)
Daniel Wroblewski, Lindsay A Brust-Sisti, Matthew Bridgeman, Mary Barna Bridgeman
Vaccines for Respiratory Syncytial Virus Prevention in Older Adults. The Annals of pharmacotherapy (2024)
Mohamed Omar Saad, Adham M Mohamed, Mohamed Izham Mohamed Ibrahim
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review. The Annals of pharmacotherapy (2024)
Anthony Gerber, Victoria Rupp, Natalia Ryabenkova, Nataliya Mikhelzon
The Impact of Glycemic Control on Sodium-Glucose Co-Transporter 2 Inhibitor-Associated Genitourinary Infections. The Annals of pharmacotherapy (2024)
Patricia Santos Reis, Durval Campos Kraychete, Emilie de Magalhães Pedreira, Eduardo Silva Reis Barreto, César Romero Antunes Júnior, Vinicius Borges Alencar, Anna Karla do Nascimento Souza, Liliane Elze Falcão Lins-Kusterer, Liana Maria Torres de Araujo Azi
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review. The Annals of pharmacotherapy (2024)
Brian Lam, Jo E Rodgers, Benyam Muluneh, Darrian Proco, Young E Whang, Katherine P Morgan
Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer. The Annals of pharmacotherapy (2024)
Karen L Hardinger, Daniel C Brennan
Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches. The Annals of pharmacotherapy (2024)
Hannah B Knox, Lisa A Dykes, Lancer A Scott, Bradley C Presley, Lara C Lambert
Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19. The Annals of pharmacotherapy (2024)
Hannah B Knox, Lisa A Dykes, Lancer A Scott, Bradley C Presley, Lara C Lambert
Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19. The Annals of pharmacotherapy (2024)
Byron Stevenson, A Joshua Roberts, William E Dager
Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure. The Annals of pharmacotherapy (2024)
Abbie L Blunier, Megan R Cheatham, Karishma S Deodhar, Christopher A Geik, Todd A Walroth, Jessica A Whitten, Christie M Davis
Evaluation of a Pharmacist-Led Implementation of Standardized Medication Administration Times for Inpatients Receiving Hemodialysis. The Annals of pharmacotherapy (2024)
Miao Zhang, Liang Huang, Yu Zhu, Linan Zeng, Zhi-Jun Jia, Guo Cheng, Hailong Li, Lingli Zhang
Epidemiology of Vancomycin in Combination With Piperacillin/Tazobactam-Associated Acute Kidney Injury in Children: A Systematic Review and Meta-analysis. The Annals of pharmacotherapy (2024)
Lyla R White, C Michael White
Eye Drop Quality Issues: Can the FDA See This One Through? The Annals of pharmacotherapy (2024)
Hayley T Gartner, Megan A Rech
Sugammadex Use Outside of the Postoperative Setting. The Annals of pharmacotherapy (2024)
James Hunter Fly, Lea S Eiland, Jeremy S Stultz
Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children. The Annals of pharmacotherapy (2024)
Caitlyn R Blankenship, Kevin D Betthauser, Laura N Hencken, Julie A Maamari, Jenna Goetz, Bria D Giacomino, Gabrielle A Gibson
Clinical Response to Third-Line Angiotensin-II vs Epinephrine in Septic Shock: A Propensity-Matched Cohort Study. The Annals of pharmacotherapy (2024)
David K Choi, Hilary Sheridan, Shubha Bhat
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2024)
David K Choi, Michelle Becker, Marina Ivanov, Shubha Bhat
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. The Annals of pharmacotherapy (2024)
Alyson M Esteves, Matthew C Buchfellner, Brooke M Holmes, Joseph A Berndsen, Matthew A Roginski
Impact of a Divided Phenobarbital Load and Taper Compared With Lorazepam Symptom Triggered Therapy in Hospitalized Patients. The Annals of pharmacotherapy (2024)
Sarita Jacob, George Iype Varughese
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy (2024)
Katherine M Kessel, Logan M Olson, Derek A Kruse, Elizabeth R Lyden, Kelsey E Whiston, Mindy M Blodgett, Alena A Balasanova
Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal. The Annals of pharmacotherapy (2024)
Jieun Yu, Da Woon Sim
A Case of Angioedema to Oral Doxycycline and Cross-Reactivity to Minocycline. The Annals of pharmacotherapy (2024)
Aylon Wisbaum, Sandrine Gaudreau, Isabelle Cloutier, Pascale Robert, Regina Kolment, Marie-France Beauchesne, Jodianne Couture
Real-Time Use of SGLT2i Verified in Pre-dialysis: The RSVP Cross-sectional Study. The Annals of pharmacotherapy (2024)

volume 58, number 4, 2024

Courtney L Bradley, Sara M McMillin, Andrew Y Hwang, Christina H Sherrill
Reply: Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Courtney L Bradley, Sara M McMillin, Andrew Y Hwang, Christina H Sherrill
Reply: Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Sarita Jacob, George Iype Varughese
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Sarita Jacob, George Iype Varughese
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Sarita Jacob, George Iype Varughese
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Courtney L Bradley, Sara M McMillin, Andrew Y Hwang, Christina H Sherrill
Reply: Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Courtney L Bradley, Sara M McMillin, Andrew Y Hwang, Christina H Sherrill
Reply: Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)
Sarita Jacob, George Iype Varughese
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice. The Annals of pharmacotherapy 58 (4) (2024)

volume 58, number 9, 2024

Kayla Lawlor
Comment: Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies. The Annals of pharmacotherapy 58 (9) (2024)
Madeline D Schultze, David J Reeves
Reply: Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies. The Annals of pharmacotherapy 58 (9) (2024)
Katherine M Kessel, Logan M Olson, Derek A Kruse, Elizabeth R Lyden, Kelsey E Whiston, Mindy M Blodgett, Alena A Balasanova
Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal. The Annals of pharmacotherapy 58 (9) (2024)
Alyson M Esteves, Matthew C Buchfellner, Brooke M Holmes, Joseph A Berndsen, Matthew A Roginski
Impact of a Divided Phenobarbital Load and Taper Compared With Lorazepam Symptom Triggered Therapy in Hospitalized Patients. The Annals of pharmacotherapy 58 (9) (2024)